TY  - GEN
AU  - McCloskey,Eugene V
AU  - Johansson,Helena
AU  - Oden,Anders
AU  - Austin,Matt
AU  - Siris,Ethel
AU  - Wang,Andrea
AU  - Lewiecki,E Michael
AU  - Lorenc,Roman
AU  - Libanati,Cesar
AU  - Kanis,John A
TI  - Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX
SN  - 1523-4681
PY  - 2012///1108
KW  - Aged
KW  - Aged, 80 and over
KW  - Algorithms
KW  - Antibodies, Monoclonal, Humanized
KW  - therapeutic use
KW  - Body Mass Index
KW  - Bone Density Conservation Agents
KW  - Denosumab
KW  - Female
KW  - Fracture Healing
KW  - Humans
KW  - Middle Aged
KW  - Osteoporosis
KW  - drug therapy
KW  - Osteoporotic Fractures
KW  - prevention & control
KW  - Placebos
KW  - Postmenopause
KW  - Probability
KW  - Proportional Hazards Models
KW  - Risk
KW  - Risk Assessment
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/jbmr.1606
ER  -